FOXO1 and non-Hodgkin lymphoma: Multiple next-generation sequencing analyses identified FOXO1 point mutations in non-Hodgkin lymphoma: around 10% in diffuse large B-cell lymphoma (DLBCL)6,7, 15% in follicular lymphoma8 and 12 to 29% in sporadic Burkitt lymphoma9,10.